Position in INSM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$89,885,137
-$77,227,397 QoQ
Shares Held
843,042
-17.5% QoQ
Ownership
0.386%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#51
of 663 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 42%
Shared 29%
None 28%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fiera Capital Corp holds $542,965,678 across 19 Biotechnology names. INSM ranks #1 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
This page
|
843,042 | $89,885,137 | |
| 2 | ARGX |
Argenx SE
|
90,423 | $83,891,746 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
1,445,885 | $53,888,133 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
99,857 | $53,618,215 | |
| 5 | QURE |
uniQure N.V.
|
909,141 | $41,875,034 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
516,997 | $29,370,599 | |
| 7 | ASND |
Ascendis Pharma A/S
|
103,313 | $27,555,643 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
405,638 | $24,484,308 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,885,137 | 843,042 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $167,112,534 | 1,021,970 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $172,802,923 | 992,892 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $116,521,514 | 809,121 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $75,282,443 | 748,037 | Shares | Other | 2025-08-08 | |
| 2025-03-31 | $44,189,990 | 579,237 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $40,171,199 | 581,854 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $43,246,295 | 592,415 | Shares | Other | 2024-11-01 | |
| 2024-06-30 | $40,570,309 | 605,527 | Shares | Other | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||